Your browser doesn't support javascript.
loading
CTLA-4+PD-1- Memory CD4+ T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques.
McGary, Colleen S; Deleage, Claire; Harper, Justin; Micci, Luca; Ribeiro, Susan P; Paganini, Sara; Kuri-Cervantes, Leticia; Benne, Clarisse; Ryan, Emily S; Balderas, Robert; Jean, Sherrie; Easley, Kirk; Marconi, Vincent; Silvestri, Guido; Estes, Jacob D; Sekaly, Rafick-Pierre; Paiardini, Mirko.
  • McGary CS; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
  • Deleage C; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702, USA.
  • Harper J; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
  • Micci L; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
  • Ribeiro SP; Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Paganini S; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
  • Kuri-Cervantes L; Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Benne C; Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Ryan ES; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
  • Balderas R; Becton Dickinson Immunosciences, San Jose, CA 95131, USA.
  • Jean S; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
  • Easley K; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Atlanta, GA 30329, USA.
  • Marconi V; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA; Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA.
  • Silvestri G; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA; Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA.
  • Estes JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702, USA.
  • Sekaly RP; Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
  • Paiardini M; Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA; Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA. Electronic address: mirko.paiardini@emory.edu.
Immunity ; 47(4): 776-788.e5, 2017 10 17.
Article en En | MEDLINE | ID: mdl-29045906
ABSTRACT
Antiretroviral therapy (ART) suppresses viral replication in HIV-infected individuals but does not eliminate the reservoir of latently infected cells. Recent work identified PD-1+ follicular helper T (Tfh) cells as an important cellular compartment for viral persistence. Here, using ART-treated, SIV-infected rhesus macaques, we show that CTLA-4+PD-1- memory CD4+ T cells, which share phenotypic markers with regulatory T cells, were enriched in SIV DNA in blood, lymph nodes (LN), spleen, and gut, and contained replication-competent and infectious virus. In contrast to PD-1+ Tfh cells, SIV-enriched CTLA-4+PD-1- CD4+ T cells were found outside the B cell follicle of the LN, predicted the size of the persistent viral reservoir during ART, and significantly increased their contribution to the SIV reservoir with prolonged ART-mediated viral suppression. We have shown that CTLA-4+PD-1- memory CD4+ T cells are a previously unrecognized component of the SIV and HIV reservoir that should be therapeutically targeted for a functional HIV-1 cure.
Asunto(s)
Antirretrovirales/uso terapéutico; Linfocitos T CD4-Positivos/efectos de los fármacos; Antígeno CTLA-4/inmunología; Receptor de Muerte Celular Programada 1/inmunología; Síndrome de Inmunodeficiencia Adquirida del Simio/tratamiento farmacológico; Virus de la Inmunodeficiencia de los Simios/efectos de los fármacos; Animales; Linfocitos T CD4-Positivos/inmunología; Linfocitos T CD4-Positivos/virología; Antígeno CTLA-4/metabolismo; Infecciones por VIH/tratamiento farmacológico; Infecciones por VIH/inmunología; Infecciones por VIH/virología; VIH-1/efectos de los fármacos; VIH-1/inmunología; VIH-1/fisiología; Interacciones Huésped-Patógeno/efectos de los fármacos; Interacciones Huésped-Patógeno/inmunología; Humanos; Memoria Inmunológica/efectos de los fármacos; Memoria Inmunológica/inmunología; Hibridación in Situ; Ganglios Linfáticos/efectos de los fármacos; Ganglios Linfáticos/inmunología; Ganglios Linfáticos/virología; Macaca mulatta; Microscopía Confocal; Receptor de Muerte Celular Programada 1/metabolismo; Síndrome de Inmunodeficiencia Adquirida del Simio/inmunología; Síndrome de Inmunodeficiencia Adquirida del Simio/virología; Virus de la Inmunodeficiencia de los Simios/inmunología; Virus de la Inmunodeficiencia de los Simios/fisiología; Linfocitos T Colaboradores-Inductores/efectos de los fármacos; Linfocitos T Colaboradores-Inductores/inmunología; Linfocitos T Colaboradores-Inductores/virología; Linfocitos T Reguladores/efectos de los fármacos; Linfocitos T Reguladores/inmunología; Linfocitos T Reguladores/virología
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Síndrome de Inmunodeficiencia Adquirida del Simio / Virus de la Inmunodeficiencia de los Simios / Antirretrovirales / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 Tipo de estudio: Prognostic_studies Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / Síndrome de Inmunodeficiencia Adquirida del Simio / Virus de la Inmunodeficiencia de los Simios / Antirretrovirales / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 Tipo de estudio: Prognostic_studies Idioma: En Año: 2017 Tipo del documento: Article